The study is the world's largest trial of treatments for hospitalised Covid-19 adults.(Reuters file photo. Representative image)
The study is the world's largest trial of treatments for hospitalised Covid-19 adults.(Reuters file photo. Representative image)

UK Covid-19 trial finds no benefit of gout drug in hospitalised adults

An independent panel suggested pausing recruitment of volunteers in the colchicine arm of the trial based on a preliminary analysis, scientists involved in UK's RECOVERY study said.
Reuters | | Posted by Harshit Sabarwal
PUBLISHED ON MAR 05, 2021 04:06 PM IST

A large British trial has halted enrolments to test gout drug colchicine as a potential treatment for patients hospitalised with Covid-19, after a sub-study of the trial found that the medication did not have any effect on the patients.

An independent panel suggested pausing recruitment of volunteers in the colchicine arm of the trial based on a preliminary analysis, scientists involved in UK's RECOVERY study said. The study is the world's largest trial of treatments for hospitalised Covid-19 adults.


SHARE THIS ARTICLE ON
Close
SHARE
Story Saved
OPEN APP